Distinct and convergent consequences of splice factor mutations in myelodysplastic syndromes

Vikas Madan, Jia Li, Siqin Zhou, Weoi Woon Teoh, Lin Han, Manja Meggendorfer, Luca Malcovati, Mario Cazzola, Seishi Ogawa, Torsten Haferlach, Henry Yang, H. Phillip Koeffler

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Myelodysplastic syndromes (MDS) are characterized by recurrent somatic alterations often affecting components of RNA splicing machinery. Mutations of splice factors SF3B1, SRSF2, ZRSR2 and U2AF1 occur in >50% of MDS. To assess the impact of spliceosome mutations on splicing and to identify common pathways/genes affected by distinct mutations, we performed RNA-sequencing of MDS bone marrow samples harboring spliceosome mutations (including hotspot alterations of SF3B1, SRSF2 and U2AF1; small deletions of SRSF2 and truncating mutations of ZRSR2), and devoid of other common co-occurring mutations. We uncover the landscape of splicing alterations in each splice factor mutant MDS and demonstrate that small deletions in SRSF2 cause highest number of splicing alterations compared with other spliceosome mutations. Although the mis-spliced events observed in different splice factor mutations were largely non-overlapping, a subset of genes, including EZH2, were aberrantly spliced in multiple mutant groups. We also verified aberrant splicing of key genes USP9X, USP24 (deubiquitinating enzymes), LUC7L2 (splice factor) and EED (PRC2 component) in MDS harboring small deletions of SRSF2. Pathway analysis revealed that mis-spliced genes in different mutant groups were enriched in RNA splicing and transport as well as several signaling cascades, suggesting converging biological consequences downstream of distinct spliceosome mutations. Our study reveals splicing signatures of each splice factor mutation and identifies shared and distinct sets of mis-spliced genes and affected biological processes in different spliceosome mutant MDS.

Original languageEnglish
JournalAmerican Journal of Hematology
DOIs
Publication statusAccepted/In press - Jan 1 2019

Fingerprint

Myelodysplastic Syndromes
Spliceosomes
Mutation
RNA Splicing
Recombinant DNA
RNA Transport
Genes
RNA Sequence Analysis
Biological Phenomena
Bone Marrow

ASJC Scopus subject areas

  • Hematology

Cite this

Madan, V., Li, J., Zhou, S., Teoh, W. W., Han, L., Meggendorfer, M., ... Koeffler, H. P. (Accepted/In press). Distinct and convergent consequences of splice factor mutations in myelodysplastic syndromes. American Journal of Hematology. https://doi.org/10.1002/ajh.25673

Distinct and convergent consequences of splice factor mutations in myelodysplastic syndromes. / Madan, Vikas; Li, Jia; Zhou, Siqin; Teoh, Weoi Woon; Han, Lin; Meggendorfer, Manja; Malcovati, Luca; Cazzola, Mario; Ogawa, Seishi; Haferlach, Torsten; Yang, Henry; Koeffler, H. Phillip.

In: American Journal of Hematology, 01.01.2019.

Research output: Contribution to journalArticle

Madan, Vikas ; Li, Jia ; Zhou, Siqin ; Teoh, Weoi Woon ; Han, Lin ; Meggendorfer, Manja ; Malcovati, Luca ; Cazzola, Mario ; Ogawa, Seishi ; Haferlach, Torsten ; Yang, Henry ; Koeffler, H. Phillip. / Distinct and convergent consequences of splice factor mutations in myelodysplastic syndromes. In: American Journal of Hematology. 2019.
@article{23e93765a4074b1fa390d49c89cc6e67,
title = "Distinct and convergent consequences of splice factor mutations in myelodysplastic syndromes",
abstract = "Myelodysplastic syndromes (MDS) are characterized by recurrent somatic alterations often affecting components of RNA splicing machinery. Mutations of splice factors SF3B1, SRSF2, ZRSR2 and U2AF1 occur in >50{\%} of MDS. To assess the impact of spliceosome mutations on splicing and to identify common pathways/genes affected by distinct mutations, we performed RNA-sequencing of MDS bone marrow samples harboring spliceosome mutations (including hotspot alterations of SF3B1, SRSF2 and U2AF1; small deletions of SRSF2 and truncating mutations of ZRSR2), and devoid of other common co-occurring mutations. We uncover the landscape of splicing alterations in each splice factor mutant MDS and demonstrate that small deletions in SRSF2 cause highest number of splicing alterations compared with other spliceosome mutations. Although the mis-spliced events observed in different splice factor mutations were largely non-overlapping, a subset of genes, including EZH2, were aberrantly spliced in multiple mutant groups. We also verified aberrant splicing of key genes USP9X, USP24 (deubiquitinating enzymes), LUC7L2 (splice factor) and EED (PRC2 component) in MDS harboring small deletions of SRSF2. Pathway analysis revealed that mis-spliced genes in different mutant groups were enriched in RNA splicing and transport as well as several signaling cascades, suggesting converging biological consequences downstream of distinct spliceosome mutations. Our study reveals splicing signatures of each splice factor mutation and identifies shared and distinct sets of mis-spliced genes and affected biological processes in different spliceosome mutant MDS.",
author = "Vikas Madan and Jia Li and Siqin Zhou and Teoh, {Weoi Woon} and Lin Han and Manja Meggendorfer and Luca Malcovati and Mario Cazzola and Seishi Ogawa and Torsten Haferlach and Henry Yang and Koeffler, {H. Phillip}",
year = "2019",
month = "1",
day = "1",
doi = "10.1002/ajh.25673",
language = "English",
journal = "American Journal of Hematology",
issn = "0361-8609",
publisher = "Wiley-Liss Inc.",

}

TY - JOUR

T1 - Distinct and convergent consequences of splice factor mutations in myelodysplastic syndromes

AU - Madan, Vikas

AU - Li, Jia

AU - Zhou, Siqin

AU - Teoh, Weoi Woon

AU - Han, Lin

AU - Meggendorfer, Manja

AU - Malcovati, Luca

AU - Cazzola, Mario

AU - Ogawa, Seishi

AU - Haferlach, Torsten

AU - Yang, Henry

AU - Koeffler, H. Phillip

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Myelodysplastic syndromes (MDS) are characterized by recurrent somatic alterations often affecting components of RNA splicing machinery. Mutations of splice factors SF3B1, SRSF2, ZRSR2 and U2AF1 occur in >50% of MDS. To assess the impact of spliceosome mutations on splicing and to identify common pathways/genes affected by distinct mutations, we performed RNA-sequencing of MDS bone marrow samples harboring spliceosome mutations (including hotspot alterations of SF3B1, SRSF2 and U2AF1; small deletions of SRSF2 and truncating mutations of ZRSR2), and devoid of other common co-occurring mutations. We uncover the landscape of splicing alterations in each splice factor mutant MDS and demonstrate that small deletions in SRSF2 cause highest number of splicing alterations compared with other spliceosome mutations. Although the mis-spliced events observed in different splice factor mutations were largely non-overlapping, a subset of genes, including EZH2, were aberrantly spliced in multiple mutant groups. We also verified aberrant splicing of key genes USP9X, USP24 (deubiquitinating enzymes), LUC7L2 (splice factor) and EED (PRC2 component) in MDS harboring small deletions of SRSF2. Pathway analysis revealed that mis-spliced genes in different mutant groups were enriched in RNA splicing and transport as well as several signaling cascades, suggesting converging biological consequences downstream of distinct spliceosome mutations. Our study reveals splicing signatures of each splice factor mutation and identifies shared and distinct sets of mis-spliced genes and affected biological processes in different spliceosome mutant MDS.

AB - Myelodysplastic syndromes (MDS) are characterized by recurrent somatic alterations often affecting components of RNA splicing machinery. Mutations of splice factors SF3B1, SRSF2, ZRSR2 and U2AF1 occur in >50% of MDS. To assess the impact of spliceosome mutations on splicing and to identify common pathways/genes affected by distinct mutations, we performed RNA-sequencing of MDS bone marrow samples harboring spliceosome mutations (including hotspot alterations of SF3B1, SRSF2 and U2AF1; small deletions of SRSF2 and truncating mutations of ZRSR2), and devoid of other common co-occurring mutations. We uncover the landscape of splicing alterations in each splice factor mutant MDS and demonstrate that small deletions in SRSF2 cause highest number of splicing alterations compared with other spliceosome mutations. Although the mis-spliced events observed in different splice factor mutations were largely non-overlapping, a subset of genes, including EZH2, were aberrantly spliced in multiple mutant groups. We also verified aberrant splicing of key genes USP9X, USP24 (deubiquitinating enzymes), LUC7L2 (splice factor) and EED (PRC2 component) in MDS harboring small deletions of SRSF2. Pathway analysis revealed that mis-spliced genes in different mutant groups were enriched in RNA splicing and transport as well as several signaling cascades, suggesting converging biological consequences downstream of distinct spliceosome mutations. Our study reveals splicing signatures of each splice factor mutation and identifies shared and distinct sets of mis-spliced genes and affected biological processes in different spliceosome mutant MDS.

UR - http://www.scopus.com/inward/record.url?scp=85075171061&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85075171061&partnerID=8YFLogxK

U2 - 10.1002/ajh.25673

DO - 10.1002/ajh.25673

M3 - Article

C2 - 31680297

AN - SCOPUS:85075171061

JO - American Journal of Hematology

JF - American Journal of Hematology

SN - 0361-8609

ER -